Analgesics in Brazil

Analgesics continue to be the most popular OTC products sold in Brazil, expected to account for around 40% of overall retail value sales of OTC products in 2024. According to Euromonitor’s Voice of the Consumer: Health and Nutrition Survey, fielded January to February 2024, 39% of Brazilians use OTC products to treat health issues, second only to the use of prescription/Rx drugs (45%). The willingness to consume OTC products means that analgesics has maintained a consistent growth trajectory ove...

Euromonitor International's Analgesics in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.